Finance

Lists
IRD:NASDAQ
Opus Genetics Inc
$5.28
-2.40%
(-0.13) 1D
$5.20
-1.52% (-0.080)
Pre-market
Closed: Sep 17, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IRD...
Open
$5.46
High
$5.62
Low
$5.23
Mkt. cap
439.27M
Avg. vol.
3.40M
Volume
562.00
52-wk high
$7.07
52-wk low
$1.41
EPS
-$1.29
Beta
0.58
Shares outstanding
83.20M
No. of employees
28
Open
$5.46
High
$5.62
Low
$5.23
Mkt. cap
439.27M
Avg. vol.
3.40M
Volume
562.00
52-wk high
$7.07
52-wk low
$1.41
EPS
-$1.29
Beta
0.58
Shares outstanding
83.20M
No. of employees
28
About Opus Genetics Inc
CEO-
Employees28
Founded2018
Headquarters-
SectorBiotechnology
Websiteopusgtx.com
Analyst ratings
Based on 14 analysts giving stock ratings to IRD in the past 3 months
Strong buy
Buy
14
Hold
0
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for IRD in the last 3 months.
Highest
Current $5.28
$20.00 (+278.79%)
Average
$13.08 (+147.73%)
Lowest
$8.00 (+51.52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Francois Brisebois
LifeSci Capital
Buy
Maintained
$20.00
+278.8%
09/12/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Reiterated
$15.00
+184.1%
09/10/2026
Thomas Shrader
BTIG
Buy
Maintained
$12.00
+127.3%
09/09/2026
Lili (Aurélie) Nsongo
Leerink Partners
Buy
Reiterated
$14.00
+165.2%
09/10/2026
Kostas Biliouris
Oppenheimer
Buy
Maintained
$20.00
+278.8%
09/09/2026
Andreas Argyrides
Chardan Capital
Buy
Reiterated
$16.00
+203%
09/09/2026
Yun Zhong
Wedbush
Buy
Maintained
$13.00
+146.2%
09/09/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
$10.00
+89.4%
09/09/2026
Matthew Caufield
H.C. Wainwright
Buy
Reiterated
$8.00
+51.5%
09/08/2026
Biren Amin
Piper Sandler
Buy
Maintained
$11.00
+108.3%
08/07/2026
James Molloy
Alliance Global Partners
Buy
Maintained
$9.00
+70.5%
08/07/2026
Lisa Walter
RBC Capital
Buy
Reiterated
$9.00
+70.5%
08/06/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
08/06/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
-
-
07/06/2026
Daniil Gataulin
Chardan Capital
Buy
Maintained
$13.00
+146.2%
07/06/2026
Debjit Chattopadhyay
Guggenheim
Buy
Initiated
$16.00
+203%
06/04/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
$11.00
+108.3%
05/13/2026
Madison Elsaadi
B. Riley Securities
Buy
Maintained
$10.00
+89.4%
04/30/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.08M
3.86M
2.16M
755.00K
Cost of goods sold
6.41M
10.43M
10.48M
11.11M
Cost of revenue
6.41M
10.43M
10.48M
11.11M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.98M
4.89M
6.04M
6.13M
Operating expense
4.98M
4.89M
6.04M
6.13M
Total operating expenses
11.39M
15.32M
16.52M
17.24M
Operating income
-8.31M
-11.45M
-14.36M
-16.48M
Other non operating income
-9.38M
-3.97M
-51.50M
7.78M
EBT including unusual items
-17.45M
-16.52M
-65.54M
-8.10M
EBT excluding unusual items
-17.45M
-16.52M
-65.54M
-8.10M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-17.45M
-16.52M
-65.54M
-8.10M
Net profit margin
-566.87%
-427.50%
-3,038.25%
-1,072.58%
Earnings per share
-0.25
-0.21
-0.75
-0.08
Interest and investment income
300.00K
300.00K
400.00K
700.00K
Interest expense
-68.00K
-1.40M
-69.00K
-100.00K
Net interest expenses
232.00K
-1.10M
331.00K
600.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.30M
-11.44M
-14.35M
-16.47M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps